IDEX (IEX): A Fresh Look at Valuation After Recent Share Price Rebound

IDEX (IEX) has quietly climbed about 11% over the past 3 months, even as its year to date and 1 year returns remain negative. That mix of recovery and lag is drawing fresh attention.

See our latest analysis for IDEX.

Zooming out, that 30 day 7.7% share price return sits alongside a weak year to date share price performance and a negative one year total shareholder return. This suggests recent momentum is rebuilding as investors reassess IDEX’s growth and risk profile.

If IDEX’s rebound has you rethinking your watchlist, this could be a good moment to scout other industrial names through aerospace and defense stocks as potential additions.

With earnings still growing and the share price trading below many analyst and intrinsic value estimates, investors now face a key question: is IDEX quietly undervalued, or is the market already pricing in its future growth?

Most Popular Narrative Narrative: 9% Undervalued

With IDEX closing at $177.19 versus a narrative fair value around the high $190s, the story hinges on how fast earnings and margins can compound.

Analysts expect earnings to reach $698.2 million (and earnings per share of $9.41) by about September 2028, up from $469.4 million today.

In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 25.8x on those 2028 earnings, down from 26.0x today.

Read the complete narrative.

Curious what kind of revenue climb, margin lift, and valuation reset are baked into that outlook? The narrative leans on ambitious compounding and a premium future multiple. Want to see exactly how those moving parts add up to the suggested fair value?

Result: Fair Value of $194.62 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, rising tariffs and sector specific softness in semiconductors and agriculture could squeeze margins and unsettle the growth story that investors are buying into.

Find out about the key risks to this IDEX narrative.

Another View: Multiples Flash a Caution Light

While narrative fair value and our model point to upside, the current price implies a price to earnings ratio of 27.7x, richer than both peers at 24.3x and a fair ratio of 25.1x. That premium narrows the margin of safety, so consider how comfortable you are paying up for quality here.

See what the numbers say about this price — find out in our valuation breakdown.

Build Your Own IDEX Narrative

If you see the numbers differently or like to dig into the data yourself, you can build a custom view in under three minutes: Do it your way.

A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding IDEX.

Ready for more investment ideas?

If IDEX has sharpened your focus, do not stop here. Expand your opportunity set now with targeted stock ideas tuned to different strategies and goals.

• Capture high potential market mispricing by acting early on these 915 undervalued stocks based on cash flows, where quality cash flows may still be trading at a discount to intrinsic worth.
• Target breakthrough innovation by scanning these 25 AI penny stocks for companies turning artificial intelligence into real revenue momentum and durable competitive advantages.
• Strengthen your income stream by reviewing these 13 dividend stocks with yields > 3%, highlighting businesses that pair healthy yields with balance sheets built to sustain payouts.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com